News


( Last Updated : March 7, 2015)

May 28, 2020
A new project on Flash Glucose Monitoring System FreeStyle Libre to Monitor Glycemia in Patients With Diabetes is now available for feedback from all interested stakeholders. Flash Glucose Monitoring System FreeStyle Libre to Monitor Glycemia in Patients With Diabetes: Draft Implementation Advice…
May 27, 2020
Media Advisory Huge response to upcoming CADTH webinar on remdesivir and hydroxychloroquine shows demand among health care decision-makers for evidence on the effectiveness of these therapies. Ottawa, Ontario — More than 1,500 people have registered for a CADTH webinar that will provide an…
May 15, 2020
OTTAWA – The CADTH Board of Directors announced today that Suzanne McGurn has been appointed as the next President and Chief Executive Officer of CADTH, effective July 6, 2020. Ms. McGurn will succeed Dr. Brian O’Rourke, who announced his retirement from CADTH in October 2019 after serving as…
May 6, 2020
In light of the COVID-19 pandemic, we’ve made some changes to our CADTH Scientific Advice Program activities. During this challenging and uncertain time, we recognize that clinical experts may not be available to participate in our projects. As input from Canadian clinical experts is key to…
May 6, 2020
CADTH has received the following notice(s) of pending drug submission(s). Brand name TBC Generic name etonogestrel Manufacturer Merck Canada Inc. Indication(s) Prevention of pregnancy Project Number SR0648-000 Call for patient…